VEGF Immunopositivity Related to Malignancy Degree, Proliferative Activity and Angiogenesis in ENU-Induced Gliomas
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bergers, G., & Benjamin, L. E. (2003). Tumorigenesis and the angiogenic switch. Nature Reviews Cancer, 3, 401–410.
Bielas, J. H., & Heddle, J. A. (2000). Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proceedings of the National Academy of Science USA, 97, 11391–11396.
Bigner, D. D., McLendon, R. E., & Bruner, J. M. (1998). Russell and Rubinstenin’s Pathology of tumors of the nervous system (6th ed.). London: Arnold.
Bulnes-Sesma, S., Ullibarri-Ortiz, N., & Lafuente-Sanchez, J. V. (2006). Tumour induction by ethylnitrosourea in the central nervous system. Revista de neurología, 43, 733–738.
Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249–257.
Chan, A. S., Leung, S. Y., Wong, M. P., Yuen, S. T., Cheung, N., Fan, Y. W., et al. (1998). Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. American Journal of Surgical Pathology, 22, 816–826.
Dvorak, H. F. (2006). Discovery of vascular permeability factor (VPF). Experimental Cell Research, 312, 522–526.
Engelbergs, J., Thomale, J., & Rajewsky, M. F. (2000). Role of DNA repair in carcinogen-induced ras mutation. Mutation Research, 450, 139–153.
Engelhard, H. H., Stelea, A., & Mundt, A. (2003). Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surgical Neurology, 60, 443–456.
Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. American Journal of Physiology Cell Physiology, 280, 1358–1366.
Ferrara, N., Gerber, H. P., & LeCouter, J. (2003). The biology of VEGF and its receptors. Natural Medicines, 9, 669–676.
Folkman, J. (2000). Tumor angiogenesis, in cancer medicine. In J. F. Holland et al. (Ed.) (p. 132:152). Hamilton, Ontario, Canada: B.C. Decker Inc.
Gil-Perotin, S., Marin-Husstege, M., Li, J., Soriano-Navarro, M., Zindy, F., Roussel, M. F., et al. (2006). Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. Journal of Neuroscience, 26, 1107–1116.
Jang, T., Litofsky, N. S., Smith, T. W., Ross, A. H., & Recht, L. D. (2004). Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis. Neurobiology of Disease, 15, 544–552.
Katayama, K., Ueno, M., Yamauchi, H., Nagata, T., Nakayama, H., & Doi, K. (2005a). Ethylnitrosourea induces neural progenitor cell apoptosis after S-phase accumulation in a p53-dependent manner. Neurobiology of Disease, 18, 218–225.
Katayama, K., Ueno, M., Yamauchi, H., Nakayama, H., & Doi, K. (2005b). Microarray analysis of genes in fetal central nervous system after ethylnitrosourea administration. Birth Defects Research, Part B, Developmental and Reproductive Toxicology, 74, 255–260.
Ke, L. D., Shi, Y. X., Im, S. A., Chen, X., & Yung, W. K. (2000). The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Clinical Cancer Research, 6, 2562–2572.
Kish, P. E., Blaivas, M., Strawderman, M., Muraszko, K. M., Ross, D. A., Ross, B. D., et al. (2001). Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: A model for experimental therapeutics of low-grade gliomas. J. Neurooncol., 53, 243–257.
Kleihues, P., & Cavenee, W. K. (2000). Pathology and genetics of tumours of the nervous system. Lyon: IARC Press.
Kokkinakis, D. M., Rushing, E. J., Shareef, M. M., Ahmed, M. M., Yang, S., Singha, U. K., et al. (2004). Physiology and gene expression characteristics of carcinogen-initiated and tumor-transformed glial progenitor cells derived from the CNS of methylnitrosourea (MNU)-treated Sprague Dawley rats. Journal of Neuropathology and Experimental Neurology, 63, 1182–1199.
Koutcher, J. A., Hu, X., Xu, S., Gade, T. P., Leeds, N., Zhou, X. J., et al. (2002). MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia, 4, 480–485.
Kroh, H. (1987). Periphery of ethylnitrosourea-induced spinal gliomas in rats with special reference to the vascular structure. Acta Neuropathologica (Berl), 73, 92–98.
Lafuente, J. V., Adan, B., Alkiza, K., Garibi, J. M., Rossi, M., & Cruz-Sanchez, F. F. (1999). Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. Journal of Molecular Neuroscience, 13, 177–185.
Lafuente, J. V., Bulnes, S., Mitre, B., & Riese, H. H. (2002). Role of VEGF in an experimental model of cortical micronecrosis. Amino Acids, 23, 241–245.
Lantos, P. L. (1986). Development of nitrosourea-induced brain tumours with a special note on changes occurring during latency. Food and Chemical Toxicology, 24, 121–127.
Machein, M. R., Knedla, A., Knoth, R., Wagner, S., Neuschl, E., & Plate, K. H. (2004). Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. American Journal of Pathology, 165, 1557–1570.
Mukherjee, J., Ghosh, A., Ghosh, A., & Chaudhuri, S. (2006). ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells. Cancer Biology and Therapy, 5, 156–164.
Nagashima, G., Suzuki, R., Asai, J., & Fujimoto, T. (2002). Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases. Clinical Neurology and Neurosurgery, 104, 125–131.
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S. Y., Sampson, D., Flynn, E., et al. (2006). A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. Journal of the National Cancer of Institute, 98, 316–325.
O’Neill, J. P. (2000). DNA damage, DNA repair, cell proliferation, and DNA replication: How do gene mutations result? Proceedings of the National Academy of Science U.S.A., 97, 11137–11139.
Plate, K. H. (1999). Mechanisms of angiogenesis in the brain. Journal of Neuropathology and Experimental Neurology, 58, 313–320.
Reifenberger, G., Kros, J. M., Louis, D. N., & Collins, V. P. (2000). Oligodendroglial tumours and mixed glioma, in pathology and genetics of tumours of the nervous system. In P. Kleihues & W. K. Cavenee (Ed.) (pp. 55–70). Lyon: IARC Press.
Reifenberger, G., & Louis, D. N. (2003). Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. Journal of Neuropathology and Experimental Neurology, 62, 111–126.
Schiffer, D., Giordana, M. T., Pezzotta, S., Lechner, C., & Paoletti, P. (1978). Cerebral tumors induced by transplacental ENU: study of the different tumoral stages, particularly of early proliferations. Acta Neuropathologica (Berl), 41, 27–31.
Schlageter, K. E., Molnar, P., Lapin, G. D., & Groothuis, D. R. (1999). Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasclar Research, 58, 312–328.
Tonini, T., Rossi, F., & Claudio, P. P. (2003). Molecular basis of angiogenesis and cancer. Oncogene, 22, 6549–6556.
Vaquero, J., Oya, S., Coca, S., & Zurita, M. (1994). Experimental induction of primitive neuro-ectodermal tumours in rats: A re-appraisement of the ENU-model of neurocarcinogenesis. Acta. Neurochirurgica, 131, 294–301.
Vaquero, J., Zurita, M., Coca, S., Oya, S., & Morales, C. (2000). Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas. Surgical Neurology, 54, 229–234.
Yoshimura, F., Kaidoh, T., Inokuchi, T., & Shigemori, M. (1998). Changes in VEGF expression and in the vasculature during the growth of early-stage ethylnitrosourea-induced malignant astrocytomas in rats. Virchows Archive, 433, 457–463.